News
The Europe GLP-1 agonists market, valued at USD 7.09 billion in 2024, is set to grow at a 17.30% CAGR, reaching USD 14.34 billion by 2034. Driven by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback